Bradley, R <br/><br/>
TSE risk assessment for starting materials used during, or in the manufacture of vaccines for human use--a consultant's view of the commercial approach.  [electronic resource] 

 -  Developments in biologicals  2006 
 - 335-45; discussion 349-54 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1424-6074 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cattle<br/>Cell Culture Techniques--standards<br/>Cell Line<br/>Encephalopathy, Bovine Spongiform--transmission<br/>Humans<br/>Prion Diseases--epidemiology<br/>Prions--isolation & purification<br/>Risk Assessment<br/>Safety<br/>Sheep<br/>Tissue Banks--standards<br/>United Kingdom<br/>Vaccines--standards